Predicting cancer outcomes with radiomics and artificial intelligence in radiology

K Bera, N Braman, A Gupta, V Velcheti… - Nature reviews Clinical …, 2022 - nature.com
The successful use of artificial intelligence (AI) for diagnostic purposes has prompted the
application of AI-based cancer imaging analysis to address other, more complex, clinical …

Radiomics: from qualitative to quantitative imaging

W Rogers, S Thulasi Seetha… - The British journal of …, 2020 - academic.oup.com
Historically, medical imaging has been a qualitative or semi-quantitative modality. It is
difficult to quantify what can be seen in an image, and to turn it into valuable predictive …

Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor …

Y Yu, Z He, J Ouyang, Y Tan, Y Chen, Y Gu, L Mao… - …, 2021 - thelancet.com
Background: in current clinical practice, the standard evaluation for axillary lymph node
(ALN) status in breast cancer has a low efficiency and is based on an invasive procedure …

MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer

Z Shi, X Huang, Z Cheng, Z Xu, H Lin, C Liu, X Chen… - Radiology, 2023 - pubs.rsna.org
Background Breast cancer is highly heterogeneous, resulting in different treatment
responses to neoadjuvant chemotherapy (NAC) among patients. A noninvasive quantitative …

Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets

GH Su, Y Xiao, C You, RC Zheng, S Zhao, SY Sun… - Science …, 2023 - science.org
Intratumor heterogeneity (ITH) profoundly affects therapeutic responses and clinical
outcomes. However, the widespread methods for assessing ITH based on genomic …

Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter …

YH Huang, T Zhu, XL Zhang, W Li, XX Zheng… - …, 2023 - thelancet.com
Background Accurate identification of pCR to neoadjuvant chemotherapy (NAC) is essential
for determining appropriate surgery strategy and guiding resection extent in breast cancer …

[HTML][HTML] Radiomics for precision medicine: Current challenges, future prospects, and the proposal of a new framework

A Ibrahim, S Primakov, M Beuque, HC Woodruff… - Methods, 2021 - Elsevier
The advancement of artificial intelligence concurrent with the development of medical
imaging techniques provided a unique opportunity to turn medical imaging from mostly …

Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer

Z Liu, X Meng, H Zhang, Z Li, J Liu, K Sun… - Nature …, 2020 - nature.com
Distant metastasis (DM) is the main cause of treatment failure in locally advanced rectal
cancer. Adjuvant chemotherapy is usually used for distant control. However, not all patients …

Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study

J Gu, T Tong, C He, M Xu, X Yang, J Tian, T Jiang… - European …, 2022 - Springer
Objectives Breast cancer (BC) is the most common cancer in women worldwide, and
neoadjuvant chemotherapy (NAC) is considered the standard of treatment for most patients …

Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment

X Wang, T Xie, J Luo, Z Zhou, X Yu, X Guo - Breast Cancer Research, 2022 - Springer
Background This study investigated the efficacy of radiomics to predict survival outcome for
locally advanced breast cancer (LABC) patients and the association of radiomics with tumor …